Aerovate Therapeutics Stock (NASDAQ:AVTE), Quotes and News Summary

Q: What sector and industry does Aerovate Therapeutics (AVTE) operate in?

Aerovate Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Aerovate Therapeutics Stock (NASDAQ: AVTE) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	0 / 146.446K
Day Range	- - -
52 Wk Range	9.410 - 32.415
Market Cap	$617.722M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	40
Short Interest	6.27%
Days to Cover	3.95

Recent News

Ermenegildo Zegna Reports FY23 Results, Joins Altice USA, Herbalife And Other Big Stocks Moving Lower On Friday

U.S. stocks were higher, with the Nasdaq Composite gaining over 100 points on Friday. Shares of Ermenegildo Zegna N.V. (NYSE: ZGN) fell sharply during Friday’s session as the company reported FY23 financial results.

Avi Kapoor

10 Short Squeeze Candidates: Getty Images, Genius Brands, MicroStrategy And More

Potential short squeeze plays gained steam in 2021 and continued through 2022, with new traders looking for the next huge move. High short interest and a high cost to borrow are among the common traits that could lead to a short squeeze.

Chris Katje

Ambrx Biopharma, PaxMedica And 3 More Short Squeeze Stocks That Could Soar This Week

Potential short squeeze plays gained steam in 2021 and have continued to attract attention, with new traders looking for the next huge move. High short interest and a high cost to borrow are among the common traits that could lead to a short squeeze.

Chris Katje

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Mar

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating

4.4

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Aerovate Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Aerovate Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing drugs ...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Aerovate Therapeutics (AVTE) stock?

You can purchase shares of Aerovate Therapeutics (NASDAQ: AVTE) through any online brokerage.

View our list of the best stock brokerages.

Who are Aerovate Therapeutics's (AVTE) competitors?

Other companies in Aerovate Therapeutics’s space includes: Cabaletta Bio (NASDAQ:CABA), Valneva (NASDAQ:VALN), Cogent Biosciences (NASDAQ:COGT), Korro Bio (NASDAQ:KRRO) and Pharming (NASDAQ:PHAR).

What is the target price for Aerovate Therapeutics (AVTE) stock?

The latest price target for Aerovate Therapeutics (NASDAQ: AVTE) was reported by Wells Fargo on Monday, April 1, 2024. The analyst firm set a price target for 35.00 expecting AVTE to rise to within 12 months (a possible 57.87% upside). 2 analyst firms have reported ratings in the last year.

Current Stock Price for Aerovate Therapeutics (AVTE)?

The stock price for Aerovate Therapeutics (NASDAQ: AVTE) is $22.17 last updated April 22, 2024 at 4:00 PM EDT.

Does Aerovate Therapeutics (AVTE) pay a dividend?

There are no upcoming dividends for Aerovate Therapeutics.

When is Aerovate Therapeutics (NASDAQ:AVTE) reporting earnings?

Aerovate Therapeutics’s Q1 earnings are confirmed for Monday, May 13, 2024.

Is Aerovate Therapeutics (AVTE) going to split?

There is no upcoming split for Aerovate Therapeutics.

What sector and industry does Aerovate Therapeutics (AVTE) operate in?

Aerovate Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-